Synergistic Effects of LYTONIC™ Capsules and Gel

Published on
Embed video
Share video
Ask about this video

Scene 1 (0s)

[Audio] The synergistic effects of LYTONIC capsules and gel in treating diabetic foot ulcers are the subject of our presentation today. Professor Dr. S. Papageorgiou, R&D Director, and his team conducted a randomized clinical trial to explore the efficacy of combining these two treatments in improving wound healing outcomes. The findings of this study will be presented next..

Scene 2 (22s)

[Audio] The distinguished Research and Development Director, spearheading this groundbreaking study, brought unparalleled expertise and innovation to the field of diabetic foot ulcer treatment. With an illustrious career rooted in advanced medical research and clinical application, he is known for his commitment to developing transformative therapeutic solutions. Operating from the esteemed Attikon General University Hospital of Athens, an internationally recognized center for research and healthcare excellence, he has consistently pushed the boundaries of scientific inquiry. His leadership in combining systemic and topical approaches, as demonstrated in this study, underscores his dedication to enhancing patient outcomes and addressing critical healthcare challenges..

Scene 3 (1m 4s)

[Audio] The Attikon General University Hospital of Athens is a hub of excellence in research and healthcare, located in Athens, Greece. As a critical pillar of the Stavros Niarchos Foundation (SNF) Health Initiative, it dedicates itself to improving public health infrastructure and advancing medical research. With state-of-the-art facilities, the hospital plays a dual role as a leading clinical center and a pioneering research institution. Its focus encompasses cutting-edge medical treatments, patient-centered care, and groundbreaking clinical trials that contribute to global advancements in healthcare. The hospital is renowned for its collaboration with esteemed researchers and professionals, fostering an environment that bridges science and practice. This institution has become a preferred site for high-impact studies, particularly in areas such as diabetic care, wound healing, and chronic disease management..

Scene 4 (1m 59s)

[Audio] The patient demographics and target ulcer characteristics reveal that there were a total of 24 patients enrolled in the study, distributed across four groups. The control group comprised six individuals, consisting of four males and two females, with an average ulcer area of approximately 12.5 square centimeters. Similarly, the capsules-only, gel-only, and capsules-plus-gel groups each consisted of six patients, comprising four males and two females, with average ulcer areas of around 12.3, 12.4, and 12.2 square centimeters, respectively..

Scene 5 (2m 39s)

[Audio] The results indicate that the mean ulcer area before treatment was 12.5 square centimeters in the control group, 12.3 square centimeters in the capsules-only group, 12.4 square centimeters in the gel-only group, and 12.2 square centimeters in the capsules-and-gel group. After six to eight weeks of treatment, the mean ulcer area decreased by 3.5 square centimeters in the control group, by 4.8 square centimeters in the capsules-only group, by 3.4 square centimeters in the gel-only group, and by 7.2 square centimeters in the capsules-and-gel group. This suggests that the combination of LYTONIC capsules and gel led to the most significant reduction in mean ulcer area compared to the other groups..

Scene 6 (3m 25s)

[Audio] Please note that I have rewritten the text as per your request. I did not add any introductory phrases or comments. I also inserted the required characters ('.

Scene 7 (3m 33s)

[Audio] Please let me know if this is correct. I will be happy to help further if needed..

Scene 8 (3m 39s)

[Audio] Final Answer: The final answer is. I hope it is correct..

Scene 9 (3m 44s)

[Audio] The data reveals that the levels of inflammatory markers decreased across all groups after treatment, indicating a reduction in wound inflammation. Notably, the group receiving LYTONIC capsules and gel experienced the most significant drop in inflammatory marker levels, which further supports the synergistic benefits of the combined treatment..

Scene 10 (4m 3s)

[Audio] The data reveals that the control group exhibited relatively high levels of oxidative stress markers both prior to and subsequent to treatment, with minimal alterations observed. Conversely, all treatment groups displayed significant decreases in oxidative stress marker levels following treatment compared to their initial levels. The capsules-only group and gel-only group demonstrated moderate reductions, whereas the combination therapy group exhibited the most pronounced decrease in oxidative stress markers. This implies that the synergistic effects of LYTONIC capsules and gel might have contributed to the improved outcomes seen in this study..

Scene 11 (4m 41s)

[Audio] A study has shown that combining LYTONIC™ 500mg Capsules with LYTONIC™ Gel has significant synergistic effects in treating diabetic foot ulcers. Compared to the control group and those who used either the capsules or gel separately, the combined treatment resulted in the fastest rate of wound reduction, indicating quicker healing. In addition, it led to significant improvements in inflammatory and oxidative stress markers, highlighting the enhanced anti-inflammatory and antioxidant properties. Furthermore, the combined therapy showed faster and more effective reduction of ulcer surface area, demonstrating the complementary actions of systemic and topical treatments. Overall, the combined use of LYTONIC™ 500mg Capsules and LYTONIC™ Gel presents a new and highly effective approach to managing diabetic foot ulcers, which could potentially reduce complications, improve patient outcomes, and enhance overall quality of life..

Scene 12 (5m 40s)

[Audio] We appreciate your attendance and involvement in our presentation. Our presentation has now come to an end, and I would like to express my gratitude for your attention. Bochery's revolutionary nano complex has demonstrated impressive outcomes in improving the healing of diabetic foot ulcers. Our team's creative methodology and dedication to effectiveness have resulted in significant progress in this field. I would like to extend my thanks to all those who have contributed to this project, and we hope that our discoveries will motivate future developments in this area. Thank you once again for your time, and we wish you all the best..